← All Companies Scinai Immunotherapeutics Ltd.
SCNI · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
Business Summary EX-10.10 6 f10k2022ex10-10_biondvax.htm EMPLOYMENT AGREEMENT DATED SEPTEMBER 5, 2018, BETWEEN BIONDVAX PHARMACEUTICALS LTD. AND ELAD MARK Exhibit 10.10
Key Facts from Earnings Calls Type Subject Detail Quarter topic_mention SCNI discussed_in_filing Healthcare & Bio topic_mention SCNI discussed_in_filing Healthcare & Bio topic_mention SCNI discussed_in_filing Healthcare & Bio topic_mention SCNI discussed_in_filing Healthcare & Bio
Annual Reports (10-K) Filed Period Accession Source Full Text 2023-04-17 2022-12-31 0001213900-23-030228 EDGAR 78K words
Quarterly Reports (10-Q) Filed Period Accession Source Full Text 2023-05-15 2023-03-31 0001213900-23-039875 EDGAR 15K words
Recent Current Reports (8-K) Filed Accession Source Full Text 2023-06-08 0001213900-23-047493 EDGAR 1K words 2023-05-11 0001213900-23-038612 EDGAR — 2023-05-04 0001213900-23-036435 EDGAR — 2023-05-04 0001213900-23-036129 EDGAR —
293 total filings indexed. 287 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers Company Identity
CIK 0001611747 Ticker SCNI Exchange Nasdaq SIC 2836: Biological Products, (No Diagnostic Substances) Incorporated L3
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance page leaf: 85e7d64dd167c0cbe2f774d691b42dac867da4a4f51c9e0d42a12bc3ae1440f5parent: 50720158436e57fd2ec08207f4abc2040c0fe3f40723d99a80a0e8f04621aa54content hash: e0124ec14293c084c30da8407f4677f5852ed531622e28cfdf6d87f32222b822signed: 2026-04-13T04:47:21.285Zsources: 2 verified data leaveschain: SEC.gov PEM → origin.rootz.global extraction → this pageverify: sha256(content_hash + parent + timestamp) = leaf